LAdd image
Livagen
LongevitySingleAlso known as: Lys-Glu-Asp-Ala
A Khavinson tetrapeptide bioregulator marketed for liver and pancreas function support.
Half-life
—
Common dose
5 – 10 mg
Dosing frequency
Daily
Administration
Subcutaneous
How it works
Theorized to act as a tissue-specific bioregulator influencing hepatic and pancreatic gene expression. Limited Western mechanistic literature.
Protocol notes
Typical protocols: 5–10 mg subcutaneously daily for 10–20 days, cycled 2–3 times per year.
Reported side effects
Reported as well-tolerated.